Gastroenterologia Japonica

, Volume 22, Issue 4, pp 428–434 | Cite as

Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer

  • Yutaka Kuwahara
  • Kazuo Kusugami
  • Kimitomo Morise
  • Kaoru Shimokata
Original Article


We investigated the effect of recombinant interferongamma (rIFN-gamma) in vitro on natural killer (NK) cell activity of peripheral blood lymphocytes (PBL) in patients with gastric cancer. Thirty untreated patients with gastric cancer and eleven healthy donors were studied.

NK cell activity in healthy donors was 38.6 ± 5.2%. In patients with gastric cancer, NK cell activity was 32.4 ± 3.9% in stage I, 35.5 ± 7.1% in stages II and III, and 22.4 ± 3.9% in stage IV. NK cell activity in stage IV patients was significantly lower than in healthy controls or gastric cancer patients in stages I–III. After stimulation by rIFNgamma, NK cell activity increased in all groups, and in stage IV patients NK cell activity recovered to normal levels. However, there was no significant increase in the proportion of Leu 7 positive or Leu 11 positive cells in PBL.

In conclusion rIFNgamma enhances the activity of NK cells, but does not increase the number of active NK cells.

Key Words

Gastric cancer Monoclonal antibodies Natural killer (NK) cell activity Recombinant interferongamma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1).
    Kadish AS, et al: Natural cytotoxicity and interferon production in human cancer: Deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol 1981, 127: 1817PubMedGoogle Scholar
  2. 2).
    Pross HF, et al: Spontaneous human lymphocytemediated cytotoxicity against tumor target cells. The effect of malignant disease. Int J Cancer 1976, 18: 593PubMedCrossRefGoogle Scholar
  3. 3).
    Lindahl P, et al: Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci 1972, 69: 721PubMedCrossRefGoogle Scholar
  4. 4).
    Heron I, et al: Regulatory effect of interferon on T cells in vitro. J Immunol 1971, 117: 1370Google Scholar
  5. 5).
    Blalock JE, et al: Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol 1980, 49: 390PubMedCrossRefGoogle Scholar
  6. 6).
    Rubin BY, et al: Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci 1980, 77: 5928PubMedCrossRefGoogle Scholar
  7. 7).
    Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Kanehara, Tokyo, 1985; 12 (Jpn)Google Scholar
  8. 8).
    Ortaldo JR, et al: Cytotoxic reactivity of human lymphocyte culture in vitro. J Immunol 1977, 119: 1351PubMedGoogle Scholar
  9. 9).
    Bloom BR, et al: Interferons and the immune system. Nature 1980, 284: 593PubMedCrossRefGoogle Scholar
  10. 10).
    Schultz RM, et al: Interferon: An inducer of macrophage activation by polyanions. Science 1977, 197: 674PubMedCrossRefGoogle Scholar
  11. 11).
    Senik A, et al: Enhancement by interferon of natural killer cell activity in mice. Cell Immunol 1979, 44: 186PubMedCrossRefGoogle Scholar
  12. 12).
    Djeu JY, et al: Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979, 122: 175PubMedGoogle Scholar
  13. 13).
    Einhorn S, et al: Interferon and spontaneous cytotoxicity in man: Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer 1978, 22: 405PubMedCrossRefGoogle Scholar
  14. 14).
    Herberman RB, et al: Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 1979, 277: 221PubMedCrossRefGoogle Scholar
  15. 15).
    Herberman RB, et al: Rule of interferon in augmentation of natural killer and antibody-dependent cellmediated cytotoxicity. Cancer Treat Rep 1978, 62: 1893PubMedGoogle Scholar
  16. 16).
    Lotzova E, et al: Stimulation of NK cell cytotoxicity potential of normal donors by two species of recombinant alpha interferon. J Interferon Res 1984, 4: 201PubMedGoogle Scholar
  17. 17).
    Esaki K, et al: Clinical and immunological study of interferons against malignant tumors. Gann no Rinsho 1983, 29: 598 (Jpn)Google Scholar
  18. 18).
    Yanagihara Y, et al: Effect of interferon-α (MOR-22) on human NK cell activity. Jpn J Cancer Chemother 1986, 13: 342 (Jpn)Google Scholar
  19. 19).
    Gibson PR, et al: Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma —Natural killer cells and their activity—. Gastroenterology 1986, 90: 12PubMedGoogle Scholar
  20. 20).
    Tanaka Y, et al: Natural cytotoxicity of healthy donor and gastric cancer patient: Correlation with the tumor stage and follow up study after surgical operation. Clin Immunol 1982, 14: 227Google Scholar
  21. 21).
    Herberman RB, et al: Natural killer cells: Characteristics and regulation of activity. Immunol Rev 1979, 44: 43PubMedCrossRefGoogle Scholar
  22. 22).
    Abo T, et al: Characterization of HNK-1 (Leu 7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capacities. J Immunol 1982, 129: 1752PubMedGoogle Scholar
  23. 23).
    Lanier LL, et al: Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flowcytometry. Immunol Rev 1983, 74: 147CrossRefGoogle Scholar
  24. 24).
    Lewis LL, et al: Subpopulations of human natural killer cells defined by expression of the Leu 7 (HNK-1) and Leu 11 (NK-15) antigens. J Immunol 1983, 131: 1789Google Scholar
  25. 25).
    Shau H, et al: Signals for activation of natural killer and natural killer-like activity. Natl Immun Cell Growth Regul 1985, 4: 113Google Scholar
  26. 26).
    Huddlestone JR, et al: Induction and kinetics of natural killer cells in humans following interferon therapy. Nature 1979, 285: 417CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1987

Authors and Affiliations

  • Yutaka Kuwahara
    • 1
  • Kazuo Kusugami
    • 1
  • Kimitomo Morise
    • 1
  • Kaoru Shimokata
    • 1
  1. 1.The First Department of Internal MedicineNagoya University School of MedicineNagoyaJapan

Personalised recommendations